
Research & Discoveries
Hamilton Completes IV Enzyme Trial for Sepsis Clotting
A completed Phase 1 trial at Hamilton Health Sciences tested intravenous DNase-I in sepsis, an approach the hospital says had not previously been attempted. The enzyme is intended to break down circulating DNA that may contribute to abnormal clotting; researchers have applied for funding for a larger Phase 2 study.







